Kiyle Huntsing
Donec sed odio operae, eu vulputate felis rhoncus. Paullum deliquit, ponderibus modulisque suis ratio utitur. Ab illo tempore, ab est sed immemorabili.
Donec sed odio operae, eu vulputate felis rhoncus. Paullum deliquit, ponderibus modulisque suis ratio utitur. Ab illo tempore, ab est sed immemorabili.
AACR Workshop Alumna Pays it Forward
Learn MoreA Simple Act: Increasing Clinical Trial Participation
Learn MoreAnnual Meeting 2022: Transitions at the National Cancer Institute
Learn MoreQ&A With Nina Bhardwaj, MD, PhD, on Tumor Immunology and Immunotherapy Advancements
Learn MoreWhat Is a ‘Tolerable’ Dose? AACR-Industry Roundtable 2025 Examines Dose Optimization
Learn MoreA Researcher’s Multifaceted Approach to Addressing Disparities in Cancer
Learn MoreAACR Journal Editors Share “Must Read” Articles for February
Learn MoreA Day on Capitol Hill
Learn MoreNew Journal Article Explores Equity in Academia
Learn MoreThe Financial Burden of Cancer: Patient-centered Outcomes Research
Learn MoreWe have made spectacular progress against cancer thanks to breakthroughs in cancer science. However, with more than 600,000 people in the United States projected to die from cancer this year, our work is not done. Get involved to ensure that the momentum continues: